Accessibility Menu
Glucose Health logo

Glucose Health(OTC) GLUC

Market Cap$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-87%
1 Year+230%
1 Month-22%
$0.35
+16.50%
+0.05Today
Glucose Health last closing stock price
MetricPriceDate
Last closeUSD 0.352026-08-03
Glucose Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.22%USD 0.322026-07-27
1 month-22.33%USD 0.452026-07-02
3 month+11.13%USD 0.312026-05-05
Year to date+64.08%USD 0.212025-12-31
1 year+229.72%USD 0.112025-08-01
3 year-2.65%USD 0.362023-08-03
5 year-86.96%USD 2.682021-08-04
Since inception-99.81%USD 187.502008-09-19

Glucose Health Financials at a Glance

Market Cap

$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$327.22K

Net Income (TTM)

-$314.08K

EPS (TTM)

-$0.02

P/E Ratio

-20.09

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.35

Volume

650

Open

$0.33

Previous Close

$0.35

Daily Range

$0.31 - $0.35

52-Week Range

$0.02 - $0.67

Estimated Earnings Date

Apr 23, 2026

GLUC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Glucose Health

Glucose Health, Inc. specializes in the creation and distribution of soluble fiber-enriched nutritional beverages. The company focuses on products designed to support individuals with pre-diabetes and diabetes, primarily under its GLUCODOWN brand.

Products and Services
  • Powdered iced tea and flavored drink mixes
  • Formulated to support blood sugar management
  • Available across North America
Growth Outlook
  • Market for diabetes management products is expanding rapidly
  • Increased consumer awareness of health and nutrition
  • Potential for product line expansion and new flavors
Financial Highlights
  • Recent quarterly revenue of $59,823, showing growth potential
  • Trailing twelve months (TTM) revenue of $339,000, indicating upward trend
  • Current ratio of 7.33, reflecting strong liquidity position
Glucose Health, Inc. operates in the packaged foods industry, focusing on health-conscious consumers. The company's products are specifically designed to cater to the growing demographic of individuals managing diabetes and pre-diabetes. With a market capitalization of approximately $6.7 million, Glucose Health is positioned to capitalize on the increasing demand for health-oriented beverages. The growth outlook for Glucose Health is promising, driven by a rising awareness of health and nutrition among consumers. The diabetes management market is expanding, providing opportunities for product line expansion and innovation. The company's focus on soluble fiber-enriched beverages aligns well with current health trends, making it a relevant player in the industry. Financially, Glucose Health has shown signs of growth, with a recent quarterly revenue of $59,823 and a trailing twelve months revenue of $339,000. The current ratio of 7.33 indicates a strong liquidity position, suggesting that the company is well-equipped to meet its short-term obligations. This financial stability, combined with a focus on a growing market, positions Glucose Health, Inc. as an intriguing option for potential investors interested in the health and wellness sector.
AI Generated • Jul 9, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

1

CEO

Mark D. Schaftlein

Website

www.glucosehealthinc.com

Headquarters

Bentonville, AR 72712, US

GLUC Financials

Key Financial Metrics (TTM)

Gross Margin

30.64%

Operating Margin

-89.38%

Net Income Margin

-95.98%

Return on Equity

471.20%

Return on Capital

-136.11%

Return on Assets

-155.25%

Earnings Yield

-4.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

26.88M

Volume

650

Avg. Volume

12.23K

Financials (TTM)

Gross Profit

$100.27K

Operating Income

-$292.46K

EBITDA

-$289.82K

Operating Cash Flow

-$78.38K

Capital Expenditure

-$4.02

Free Cash Flow

-$78.39K

Cash & ST Invst.

$51.02K

Total Debt

$2.18K

Glucose Health Performance Analysis

Glucose Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,072,65512.5%
20232023-12-31USD 534,724-50.1%
20242024-12-31USD 384,078-28.2%
20252025-12-31USD 340,659-11.3%
Glucose Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3014.6%
Q32025-09-30-30.8%
Q42025-12-31115.7%
Q12026-03-31-52.3%
Glucose Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.0533.5%
20232023-12-31USD -0.03-35.2%
20242024-12-31USD -0.03-13.3%
20252025-12-31USD -0.02-31.4%
Glucose Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-11.9%
Q32025-09-3016.7%
Q42025-12-31105.5%
Q12026-03-31-2000.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$59.82K

-18.3%

Gross Profit

-$3.93K

-126.2%

Gross Margin

-6.57%

N/A

Market Cap

$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.13M

N/A

Employees

3

N/A

Net Income

-$159.82K

-119.6%

EBITDA

-$159.16K

-139.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$51.02K

+609.1%

Total Debt

$2.18K

-99.1%

Accounts Receivable

$39.57K

+90.8%

Inventory

$94.33K

-56.6%

Long Term Debt

$0.00

N/A

Short Term Debt

$2.18K

-99.1%

Return on Assets

-1.55%

N/A

Return on Invested Capital

-1.65%

N/A

Free Cash Flow

-$81.92K

-324.0%

Operating Cash Flow

-$81.92K

-324.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LTRELearning Tree International, Inc.
$0.66+0.00%
VPRBVPR Brands, LP
$0.12-2.70%
PNGAFThe Precision Peptide Company Inc
$0.35+10.32%
CYANCyanotech Corporation
$0.53+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About GLUC

What is the current price of Glucose Health?

Glucose Health is trading at $0.35 per share.

What is the 52-week range for Glucose Health?

Over the past 52 weeks, Glucose Health has traded between $0.02 and $0.67.

How much debt does Glucose Health have?

As of the most recent reporting period, Glucose Health reported total debt of $2.18K.

How much cash does Glucose Health have on hand?

Glucose Health reported $51.02K in cash and cash equivalents in its most recent financial results.

What is Glucose Health’s dividend yield?

Glucose Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services